Previous Close | 28.32 |
Open | 28.58 |
Bid | 28.50 x 51100 |
Ask | 26.71 x 25600 |
Day's Range | 28.42 - 28.74 |
52 Week Range | 21.14 - 36.37 |
Volume | |
Avg. Volume | 2,190,682 |
Market Cap | 42.273B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | 30.57 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.29 (1.01%) |
Ex-Dividend Date | Feb 07, 2024 |
1y Target Est | N/A |
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beyond analysts' top -and-bottom-line estimates for ResMed (RMD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.